StonvexLoading…
StonvexStonvexStonvexCore line items from F's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $187.27B | $184.99B | $176.19B | $158.06B |
Operating Income | $-9.17B | $5.22B | $5.46B | $6.28B |
Net Income | $-8.16B | $5.88B | $4.35B | $-1.98B |
EPS (Diluted) | $-2.06 | $1.46 | $1.08 | $-0.49 |
Total Assets | $289.16B | $285.20B | $273.31B | $255.88B |
Total Liabilities | $253.18B | $240.34B | $230.51B | $212.72B |
Cash & Equivalents | $23.36B | $22.93B | $24.86B | $25.13B |
Free Cash Flow OCF − CapEx | $12.47B | $6.74B | $6.68B | $-13.00M |
Shares Outstanding | 3.98B | 4.02B | 4.04B | 4.01B |